<body><script type="text/javascript"> function setAttributeOnload(object, attribute, val) { if(window.addEventListener) { window.addEventListener('load', function(){ object[attribute] = val; }, false); } else { window.attachEvent('onload', function(){ object[attribute] = val; }); } } </script> <div id="navbar-iframe-container"></div> <script type="text/javascript" src="https://apis.google.com/js/platform.js"></script> <script type="text/javascript"> gapi.load("gapi.iframes:gapi.iframes.style.bubble", function() { if (gapi.iframes && gapi.iframes.getContext) { gapi.iframes.getContext().openChild({ url: 'https://www.blogger.com/navbar.g?targetBlogID\x3d1042626312146086864\x26blogName\x3dHealth+News\x26publishMode\x3dPUBLISH_MODE_BLOGSPOT\x26navbarType\x3dBLUE\x26layoutType\x3dCLASSIC\x26searchRoot\x3dhttps://medreader.blogspot.com/search\x26blogLocale\x3den_US\x26v\x3d2\x26homepageUrl\x3dhttp://medreader.blogspot.com/\x26vt\x3d-963894902553858859', where: document.getElementById("navbar-iframe-container"), id: "navbar-iframe" }); } }); </script>

Blog Team

Categories

Archives

Links

« Home | Obesity Heightens Kidney Disease Risks » | Minorities at higher risk of arthritis disability » | Personality may influence irritable bowel syndrome » | Insomnia may lead to toilet visits, study finds » | Ovarian Tissue Successfully Transplanted in Sisters » | Health Tip: Coping With Menopause » | Abstinence Programs Don't Cut HIV Risk » | Health Tip: Understanding Deep Vein Thrombosis » | Many Heart Attack Patients Don't Get Needed Treatment » | Drinking While Pregnant May Alter Child's Brain »

Trial vaccine may slow breast cancer tumors


A vaccine designed to treat breast cancer appeared to be safe in women with advanced disease and showed signs of actually slowing down tumors, U.S. researchers reported on Friday.

Dendreon Corporation, maker of the Provenge prostate cancer vaccine, calls the new vaccine Neuvenge. It targets a type of breast cancer called her2/neu-positive breast cancer, which affects between 20 percent and 30 percent of breast cancer patients.

Like Provenge, Neuvenge is made using immune cells from the cancer patient, so it is a tailor-made vaccine.

SOURSE - Washington Post

| Tags: Breast Cancer, Cancer, Public Health and Safety, Women's Health |

Labels: , , , ,

Posted by Klodian on August 18, 2007 at 9:52 PM | Digg it | Del.icio.us

Very interesting article - I have done some research on the link between Breast Cancer and Antiperspirants. Please click 'SolidInfo' for more information.

Posted by Anonymous Anonymous | February 11, 2008 at 3:11 PM  

Post a Comment